AI Medical Compendium Journal:
The Lancet. Infectious diseases

Showing 1 to 5 of 5 articles

Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial.

The Lancet. Infectious diseases
BACKGROUND: Lymphatic filariasis caused by Wuchereria bancrofti causes hydroceles and lymphedema in millions of individuals worldwide. Annual mass drug administration of ivermectin plus albendazole (IA) temporarily clears microfilariae from the blood...

Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop.

The Lancet. Infectious diseases
Health-care systems, food supply chains, and society in general are threatened by the inexorable rise of antimicrobial resistance. This threat is driven by many factors, one of which is inappropriate antimicrobial treatment. The ability of policy mak...